Historically, patient management decisions have been based on histologic analyses, i.e., tumor size, grade, proliferation indices, lymph node status, and presence of hormone receptors: estrogen (ER), progesterone (PR), and epidermal growth factor receptor 2 (Her2). Here, ERBB2 is linked to neoplasm.